Arrhythmogenic mechanisms in ryanodine receptor channelopathies

Yan-Ting Zhao1, Carmen R Valdivia, Georgina B Gurrola

  • 1Center for Arrhythmia Research, Department of Internal Medicine, Cardiovascular Division, University of Michigan, Ann Arbor, MI, 48109, USA.

Insights

Ryanodine receptor (RyR2) mutations cause catecholaminergic polymorphic ventricular tachycardia (CPVT) through abnormal calcium (Ca2+) release. Most mutations cause hyperactive RyR2 channels, but some cause hypoactive channels, requiring new explanations for arrhythmias.

Area of Science:

  • Cardiovascular Physiology
  • Molecular Cardiology
  • Ion Channel Function

Background:

  • Ryanodine receptors (RyRs) are crucial calcium (Ca2+) release channels in muscle cells.
  • Dysfunctional RyRs, particularly RyR2 mutations, are linked to cardiac arrhythmias like catecholaminergic polymorphic ventricular tachycardia (CPVT).

Purpose of the Study:

  • To review arrhythmogenic mechanisms caused by RyR2 mutations in CPVT.
  • To explore how both gain-of-function and loss-of-function RyR2 mutations contribute to ventricular arrhythmias.

Main Methods:

  • Literature review of studies on RyR2 mutations and CPVT.
  • Analysis of cellular mechanisms underlying RyR2-mediated calcium (Ca2+) release and its impact on cardiac electrical activity.

Main Results:

  • Most CPVT-associated RyR2 mutations result in hyperactive channels causing spontaneous Ca2+ release during diastole.
  • This spontaneous release can lead to delayed afterdepolarizations (DADs) and ventricular arrhythmias.
  • A subset of CPVT mutations leads to hypoactive RyR2 channels, with unclear mechanisms for arrhythmia generation.

Conclusions:

  • RyR2 channel dysfunction is a key driver of CPVT.
  • While gain-of-function mutations are well-understood, novel mechanisms are needed to explain arrhythmias from loss-of-function RyR2 mutations.

Related Concept Videos

Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
2.7K
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
4.4K
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
3.0K
Electrophysiology of Normal Cardiac Rhythm01:19

Electrophysiology of Normal Cardiac Rhythm

The normal cardiac rhythm is a synchronized electrical activity that facilitates the regular and coordinated contraction of the heart muscle. This process is essential for efficient blood circulation throughout the body. The fundamental elements involved in establishing and maintaining this rhythm include the unique electrical properties of cardiac muscle cells, the sinoatrial (SA) node's pacemaker function, the specialized conducting system, and the ionic mechanisms underlying each phase...
10.6K
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers01:20

Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers

Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
2.8K
Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
5.5K